Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

37.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
37.5K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.7K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

4.2K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
4.2K
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

3.1K
The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily...
3.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.5K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

3.1K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing ARR Versus Suppressed PRA as Screening Tests for Primary Aldosteronism.

Hypertension (Dallas, Tex. : 1979)·2024
Same author

Who and How Should We Screen for Primary Aldosteronism?

Hypertension (Dallas, Tex. : 1979)·2023
Same author

Recognising primary aldosteronism as a disorder in its own right.

The Medical journal of Australia·2023
Same author

Primary Aldosteronism: Imaging vs. Lateralization.

American journal of hypertension·2022
Same author

Primary Aldosteronism: Where Are We Now? Where to From Here?

Hypertension (Dallas, Tex. : 1979)·2022
Same author

Primary Aldosteronism: Three Strikes and Out.

Hypertension (Dallas, Tex. : 1979)·2021

Related Experiment Video

Updated: Apr 19, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.6K

Primary aldosteronism and salt.

John W Funder1

  • 1MIMR-PHI Institute (formerly Prince Henry's Institute), 27-31 Wright Street, Clayton, VIC, 3168, Australia, john.funder@princehenrys.org.

Pflugers Archiv : European Journal of Physiology
|December 16, 2014
PubMed
Summary
This summary is machine-generated.

Primary aldosteronism is more common and dangerous than previously believed, affecting up to 30% of hypertensive patients. This condition, linked to salt sensitivity, requires a reevaluation of hypertension treatments.

More Related Videos

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

6.1K
Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

9.9K

Related Experiment Videos

Last Updated: Apr 19, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

24.6K
Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
09:29

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells

Published on: March 5, 2019

6.1K
Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats
10:28

Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats

Published on: December 5, 2017

9.9K

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Nephrology

Background:

  • Primary aldosteronism was historically considered rare (<1%) and benign.
  • Current estimates suggest 5-10% of hypertensive individuals have primary aldosteronism.
  • Emerging evidence indicates autonomous aldosterone secretion may affect up to 30% of hypertensives.

Purpose of the Study:

  • To re-evaluate the prevalence and clinical significance of primary aldosteronism.
  • To explore the mechanisms underlying cardiovascular and renal damage in primary aldosteronism.
  • To propose changes in antihypertensive therapy based on updated prevalence data.

Main Methods:

  • Review of current epidemiological data and clinical consensus on primary aldosteronism.
  • Analysis of the relationship between aldosterone levels, sodium status, and cardiovascular outcomes.
  • Consideration of potential contributing factors like endogenous ouabain and salt intake.

Main Results:

  • Primary aldosteronism is significantly more prevalent (potentially ~30%) and poses a higher risk than previously thought.
  • Cardiovascular and renal damage in primary aldosteronism is linked to inappropriate aldosterone levels relative to sodium status, not solely high blood pressure.
  • High salt intake may disproportionately affect hypertensive individuals with autonomous aldosterone secretion.

Conclusions:

  • Primary aldosteronism is a common and serious condition requiring a paradigm shift in understanding.
  • The pathophysiology involves disturbed sodium-aldosterone feedback loops, potentially exacerbated by factors like endogenous ouabain.
  • A reassessment of first-line antihypertensive strategies is warranted given the high prevalence and risks associated with primary aldosteronism.